These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 38183614)

  • 1. The Microbiome and Acne: Perspectives for Treatment.
    Dessinioti C; Katsambas A
    Dermatol Ther (Heidelb); 2024 Jan; 14(1):31-44. PubMed ID: 38183614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propionibacterium (Cutibacterium) acnes Bacteriophage Therapy in Acne: Current Evidence and Future Perspectives.
    Castillo DE; Nanda S; Keri JE
    Dermatol Ther (Heidelb); 2019 Mar; 9(1):19-31. PubMed ID: 30539425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics and Antimicrobial Resistance in Acne: Epidemiological Trends and Clinical Practice Considerations.
    Dessinioti C; Katsambas A
    Yale J Biol Med; 2022 Dec; 95(4):429-443. PubMed ID: 36568833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-antibiotic Isotretinoin Treatment Differentially Controls
    Ryan-Kewley AE; Williams DR; Hepburn N; Dixon RA
    Front Microbiol; 2017; 8():1381. PubMed ID: 28790988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Skin Microbiome: A New Actor in Inflammatory Acne.
    Dréno B; Dagnelie MA; Khammari A; Corvec S
    Am J Clin Dermatol; 2020 Sep; 21(Suppl 1):18-24. PubMed ID: 32910436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acne microbiome: From phyla to phylotypes.
    Dreno B; Dekio I; Baldwin H; Demessant AL; Dagnelie MA; Khammari A; Corvec S
    J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):657-664. PubMed ID: 37777343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunomodulatory potential of phage therapy to treat acne: a review on bacterial lysis and immunomodulation.
    Farfán J; Gonzalez JM; Vives M
    PeerJ; 2022; 10():e13553. PubMed ID: 35910763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in understanding
    Platsidaki E; Dessinioti C
    F1000Res; 2018; 7():. PubMed ID: 30613388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The increasing importance of the gut microbiome in acne vulgaris.
    Siddiqui R; Makhlouf Z; Khan NA
    Folia Microbiol (Praha); 2022 Dec; 67(6):825-835. PubMed ID: 35711021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Topically Applied Selected Cutibacterium acnes Strains over Five Weeks in Patients with Acne Vulgaris: An Open-label, Pilot Study.
    Karoglan A; Paetzold B; Pereira de Lima J; Brüggemann H; Tüting T; Schanze D; Güell M; Gollnick H
    Acta Derm Venereol; 2019 Dec; 99(13):1253-1257. PubMed ID: 31573666
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Boyanova L
    Future Microbiol; 2023 Mar; 18():235-244. PubMed ID: 37042433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects of Phage Application in the Treatment of Acne Caused by
    Jończyk-Matysiak E; Weber-Dąbrowska B; Żaczek M; Międzybrodzki R; Letkiewicz S; Łusiak-Szelchowska M; Górski A
    Front Microbiol; 2017; 8():164. PubMed ID: 28228751
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent advances in understanding inflammatory acne: Deciphering the relationship between Cutibacterium acnes and Th17 inflammatory pathway.
    Mias C; Mengeaud V; Bessou-Touya S; Duplan H
    J Eur Acad Dermatol Venereol; 2023 Mar; 37 Suppl 2():3-11. PubMed ID: 36729400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference and co-existence of staphylococci and Cutibacterium acnes within the healthy human skin microbiome.
    Ahle CM; Stødkilde K; Poehlein A; Bömeke M; Streit WR; Wenck H; Reuter JH; Hüpeden J; Brüggemann H
    Commun Biol; 2022 Sep; 5(1):923. PubMed ID: 36071129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are antibiotics still relevant in acne? A review of the therapeutic conundrum.
    Monteiro RC; Fernandes M
    Int J Dermatol; 2024 Mar; 63(3):306-310. PubMed ID: 37743606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates.
    Dréno B; Pécastaings S; Corvec S; Veraldi S; Khammari A; Roques C
    J Eur Acad Dermatol Venereol; 2018 Jun; 32 Suppl 2():5-14. PubMed ID: 29894579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical phage therapy in a mouse model of Cutibacterium acnes-induced acne-like lesions.
    Rimon A; Rakov C; Lerer V; Sheffer-Levi S; Oren SA; Shlomov T; Shasha L; Lubin R; Zubeidat K; Jaber N; Mujahed M; Wilensky A; Coppenhagen-Glazer S; Molho-Pessach V; Hazan R
    Nat Commun; 2023 Feb; 14(1):1005. PubMed ID: 36813793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Susceptibility, Biotypes and Phylotypes of Clinical Cutibacterium (Formerly Propionibacterium) acnes Strains Isolated from Acne Patients: An Observational Study.
    Zhang N; Yuan R; Xin KZ; Lu Z; Ma Y
    Dermatol Ther (Heidelb); 2019 Dec; 9(4):735-746. PubMed ID: 31538294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microbiome in preadolescent acne: Assessment and prospective analysis of the influence of benzoyl peroxide.
    Ahluwalia J; Borok J; Haddock ES; Ahluwalia RS; Schwartz EW; Hosseini D; Amini S; Eichenfield LF
    Pediatr Dermatol; 2019 Mar; 36(2):200-206. PubMed ID: 30656737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Dysbiosis to Healthy Skin: Major Contributions of
    Rozas M; Hart de Ruijter A; Fabrega MJ; Zorgani A; Guell M; Paetzold B; Brillet F
    Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33803499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.